Are new drugs as good as they claim to be?

Australian Prescriber

Volumn 27, Issue 1, 2004, Pages 2-3

  Lexchin, Joel ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b YORK UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Advertising; Drug information; Effectiveness; Pharmaceutical industry

Indexed keywords

CELECOXIB; CERIVASTATIN; CISAPRIDE; CITALOPRAM; CYCLOOXYGENASE 2 INHIBITOR; ESCITALOPRAM; ESOMEPRAZOLE; OMEPRAZOLE; PLACEBO;

AUSTRALIA; CLINICAL TRIAL; COMPARATIVE STUDY; DISABILITY; DRUG APPROVAL; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; EDITORIAL; ENANTIOMER; FINANCIAL MANAGEMENT; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; LICENSING; META ANALYSIS; PATENT; PRESCRIPTION; RACEMIC MIXTURE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0842334033     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2004.001     Document Type: Editorial

References (7)

1. Mansfield PR. Spending on drug promotion. Estimated spending on drug promotion in Australia in 2003. Healthy Skepticism web site. http://www.healthyskepticism.org/promotion/spending.htm [cited 2003 December 22]
2. Do single stereoisomer drugs provide value? Therapeutics Letter 2002;45. http://www.ti.ubc.ca/pages/letter45.htm [cited 2003 December 22]
3. Svensson S, Mansfield PR. Escitalopram: superior to citalopram or a chiral chimera? Psychother Psychosom 2004;73:10-6.
4. Wright JM. The double-edged sword of COX-2 selective NSAIDs. CMAJ 2002;167:1131-7
5. Lexchin J. New drugs with novel therapeutic characteristics. Have they been subject to randomized controlled trials? Can Fam Physician 2002;48:1487-92.
6. Temple R. Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA 1999;282:790-5.
7. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Br Med J 2003;326:1167-70.